Evaluation study to measure the cardiovascular risk of psoriasis patients during dermatological rehabilitation (KARPSOReha)

• Conditions: L40.0; Psoriasis vulgaris

• Registration Number: DRKS00033195
• Lead Sponsor: Fachklinik Bad Bentheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-08-11
• Study Start: 2023-12-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

Diagnosis Psoriasis

Exclusion Criteria

- exclusion of patients who are affiliated with the sponsor, study director, or responsible physician
- exclusion of patients who are unable to accurately and truthfully complete the questionnaires.
- exclusion of patients, who are incapable of giving their informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiorespiratory fitness, measured by steep ramp test (using cycle ergometry) on day 1 and 21 of dermatological rehabilitation

Secondary Outcome Measures

Name	Time	Method
icotine consumption, alcohol consumption, arterial blood pressure, pulse, weight/BMI, abdominal circumference, fasting blood glucose, laboratory parameters: Triglycerides, total cholesterol, LDL, HDL, GOT, GPT, GGT and hs-CRP.<br>DLQI, PASI, PtGA, NRS pruritus, satisfaction with treatment options in rehabilitation, subjective treatment success